Therapeutic Potential of Zinc Oxide-Loaded Syringic Acid Against in vitro and in vivo Model of Lung Cancer

Ning Yang,1 Feng Qiu,2 Feng Zhu,3 Lei Qi4 1Tumor Research and Therapy Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, People’s Republic of China; 2Department of Pain Management, Shandong Provincial Hospital Affiliated to Shandon...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yang N, Qiu F, Zhu F, Qi L
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	zinc oxide nanoparticles syringic acid lung cancer apoptosis a549 Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/fd84cc7bc24d4d3ab20a5d5fc3a3c638
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:fd84cc7bc24d4d3ab20a5d5fc3a3c638
record_format	dspace
spelling	oai:doaj.org-article:fd84cc7bc24d4d3ab20a5d5fc3a3c6382021-12-02T11:16:41ZTherapeutic Potential of Zinc Oxide-Loaded Syringic Acid Against in vitro and in vivo Model of Lung Cancer1178-2013https://doaj.org/article/fd84cc7bc24d4d3ab20a5d5fc3a3c6382020-10-01T00:00:00Zhttps://www.dovepress.com/therapeutic-potential-of-zinc-oxide-loaded-syringic-acid-against-in-vi-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Ning Yang,1 Feng Qiu,2 Feng Zhu,3 Lei Qi4 1Tumor Research and Therapy Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, People’s Republic of China; 2Department of Pain Management, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China; 3Department of Thoracic Surgery, Shandong Provincial Chest Hospital, Jinan, Shandong 250013, People’s Republic of China; 4Department of Thoracic Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province 250012, People’s Republic of ChinaCorrespondence: Lei QiDepartment of Thoracic Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, No. 107 Wenhuaxi Road, Jinan, Shandong Province 250012, People’s Republic of ChinaEmail walker789sdu@sina.comIntroduction: Lung cancer is one of the most aggressive forms of cancer that leads to a high mortality rate amongst several cancer types and it is a widely recurrent cancer globally. The use of zinc oxide nanoparticles (ZnONPs) in the formulation of sun cream, food flavors, and colorings due to its varied biological properties. The extensive significance of nanoparticles encourages their production but the approaches are a common challenge in concluding the direct beneficial effect for the disease treatment. Hence, in the present study, zinc oxide-loaded syringic acid (ZnO-SYR) phytochemical was used to elucidate the therapeutic effect against lung cancer.Methods: The ZnO-SYR nanoparticles were synthesized and characterized by UV-visible spectroscopy, X-ray diffraction, dynamic light scattering, and FT-IR analysis. The characterized ZnO-SYR was tested on in vivo mouse model of lung cancer (benzo(a)pyrene (BAP)) and in vitro A549 cells.Results: The results demonstrated the significant restoration of body weight with attenuated serum marker enzymes compared to BAP-treated animals. In addition, cytokine estimation revealed ameliorated levels of TNF-α, interleukins, IL-6, IL-1β with evidenced histological observations in ZnO-SYR-treated mice compared to BAP-induced lung cancer mice.Discussion: Furthermore, cytotoxicity analysis demonstrated the altered mitochondrial membrane potential (MMP), with a profound increase in reactive oxygen species (ROS) levels, and apoptosis mechanism by ZnO-SYR compared to control cells. The conclusions of the present study put forward an evident confirmation of the protective and beneficial effects of zincoxide-loaded syringic acid against the BAP-induced lung cancer model.Keywords: zinc oxide nanoparticles, syringic acid, lung cancer, apoptosis, A549Yang NQiu FZhu FQi LDove Medical Pressarticlezinc oxide nanoparticlessyringic acidlung cancerapoptosisa549Medicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 8249-8260 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	zinc oxide nanoparticles syringic acid lung cancer apoptosis a549 Medicine (General) R5-920
spellingShingle	zinc oxide nanoparticles syringic acid lung cancer apoptosis a549 Medicine (General) R5-920 Yang N Qiu F Zhu F Qi L Therapeutic Potential of Zinc Oxide-Loaded Syringic Acid Against in vitro and in vivo Model of Lung Cancer
description	Ning Yang,1 Feng Qiu,2 Feng Zhu,3 Lei Qi4 1Tumor Research and Therapy Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, People’s Republic of China; 2Department of Pain Management, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China; 3Department of Thoracic Surgery, Shandong Provincial Chest Hospital, Jinan, Shandong 250013, People’s Republic of China; 4Department of Thoracic Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province 250012, People’s Republic of ChinaCorrespondence: Lei QiDepartment of Thoracic Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, No. 107 Wenhuaxi Road, Jinan, Shandong Province 250012, People’s Republic of ChinaEmail walker789sdu@sina.comIntroduction: Lung cancer is one of the most aggressive forms of cancer that leads to a high mortality rate amongst several cancer types and it is a widely recurrent cancer globally. The use of zinc oxide nanoparticles (ZnONPs) in the formulation of sun cream, food flavors, and colorings due to its varied biological properties. The extensive significance of nanoparticles encourages their production but the approaches are a common challenge in concluding the direct beneficial effect for the disease treatment. Hence, in the present study, zinc oxide-loaded syringic acid (ZnO-SYR) phytochemical was used to elucidate the therapeutic effect against lung cancer.Methods: The ZnO-SYR nanoparticles were synthesized and characterized by UV-visible spectroscopy, X-ray diffraction, dynamic light scattering, and FT-IR analysis. The characterized ZnO-SYR was tested on in vivo mouse model of lung cancer (benzo(a)pyrene (BAP)) and in vitro A549 cells.Results: The results demonstrated the significant restoration of body weight with attenuated serum marker enzymes compared to BAP-treated animals. In addition, cytokine estimation revealed ameliorated levels of TNF-α, interleukins, IL-6, IL-1β with evidenced histological observations in ZnO-SYR-treated mice compared to BAP-induced lung cancer mice.Discussion: Furthermore, cytotoxicity analysis demonstrated the altered mitochondrial membrane potential (MMP), with a profound increase in reactive oxygen species (ROS) levels, and apoptosis mechanism by ZnO-SYR compared to control cells. The conclusions of the present study put forward an evident confirmation of the protective and beneficial effects of zincoxide-loaded syringic acid against the BAP-induced lung cancer model.Keywords: zinc oxide nanoparticles, syringic acid, lung cancer, apoptosis, A549
format	article
author	Yang N Qiu F Zhu F Qi L
author_facet	Yang N Qiu F Zhu F Qi L
author_sort	Yang N
title	Therapeutic Potential of Zinc Oxide-Loaded Syringic Acid Against in vitro and in vivo Model of Lung Cancer
title_short	Therapeutic Potential of Zinc Oxide-Loaded Syringic Acid Against in vitro and in vivo Model of Lung Cancer
title_full	Therapeutic Potential of Zinc Oxide-Loaded Syringic Acid Against in vitro and in vivo Model of Lung Cancer
title_fullStr	Therapeutic Potential of Zinc Oxide-Loaded Syringic Acid Against in vitro and in vivo Model of Lung Cancer
title_full_unstemmed	Therapeutic Potential of Zinc Oxide-Loaded Syringic Acid Against in vitro and in vivo Model of Lung Cancer
title_sort	therapeutic potential of zinc oxide-loaded syringic acid against in vitro and in vivo model of lung cancer
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/fd84cc7bc24d4d3ab20a5d5fc3a3c638
work_keys_str_mv	AT yangn therapeuticpotentialofzincoxideloadedsyringicacidagainstinvitroandinvivomodeloflungcancer AT qiuf therapeuticpotentialofzincoxideloadedsyringicacidagainstinvitroandinvivomodeloflungcancer AT zhuf therapeuticpotentialofzincoxideloadedsyringicacidagainstinvitroandinvivomodeloflungcancer AT qil therapeuticpotentialofzincoxideloadedsyringicacidagainstinvitroandinvivomodeloflungcancer
_version_	1718396094310776832

Therapeutic Potential of Zinc Oxide-Loaded Syringic Acid Against in vitro and in vivo Model of Lung Cancer

Ejemplares similares